Viroterapi Sebagai Terapi Kanker

Dian Mardiani, Titiek Djannatun

Abstract


The development of molecular biology and genetic engineering, now allow the formation of an effective and specific cancer treatment. Modern cancer treatment has grown rapidly, thus giving a chance to discover a new method that is more promising than the previous treatment. Virotherapy is one of cancer therapy that use the replication-competent viruses to destroy cancer cells. Oncolytic virus (virus used as virotherapy) must be modified by genetic engineering before it can be used as virotherapy.Once modified, oncolytic virus destroys cancer cells through the replication, apoptosis induction, cell lysis through the release of progeny viruses, and activation of immune system. The immune system will be responsible for neutralizing the virus after tumour lysis process, and the immune system will also destroy the remaining tumor cells, although virus already neutralized from the body.

Keywords


Virotherapy, Oncolytic virus, Virus as anticancer

Full Text:

PDF

References


American Cancer Society. 2011. Cancer Facts and Figures 2011. American Cancer Society Inc, Atlanta. American Society of Clinical Oncology (ASCO). 2011.

Types of Treatment. American Society of Clinical Oncology, Alexandria. (Available at; http://www.cancer.net/all-about- cancer/treating-cancer/types-treatment). Diakses pada 18 Maret 2013.

Baratawidjaja KG and Rengganis I. 2009. Imunologi Infeksi: Imunologi Dasar, 8th ed, hal. 399 – 449. Balai Penerbit FKUI, Jakarta.

Chen NG and Szalay AA. 2011. Oncolytic Virotherapy of Cancer: Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures (Minev B.R., ed), hal. 295 – 316. Springer Dordrecht Heidelberg, London.

Departemen Kesehatan RI 2002. Kanker Penyebab Kematian Keenam Terbesar di Indonesia.

Departemen Kesehatan RI, Jakarta. (Diakses dari; http://www.depkes.go.id/index.php/berita/info

-umum-kesehatan/539-kanker-penyebab-kematian-keenam-terbesar-di-indonesia.html. ). Diakses pada 18 Maret

Desen W and Japaries W. 2011. Pendahuluan: Onkologi Klinis, ed 2nd, hlm. 3 – 4. Fakultas Kedokteran Universitas Indonesia, Jakarta.

Garber, K. 2006. China Approves World First Oncolytic Virus Therapy for Cancer Treatment. Journal of the National Cancer Institute, Oxford.

Kelly E and Russell SJ. 2007. History of Oncolytic Viruses: Genesis to Genetic Engineering. The American Society of Gene Therapy, Minnesota.

Liu G and Robins HI. 2011. The Natural History and Biology of Cancer: IUCC Manual of Clinical Oncology (Pollock R.E. ed), 8th ed, hal. 1 - 8.

John Wiley & Sons Inc, New Jersey. Meerani S and Yao Y. 2010. Oncolytic Viruses in Cancer Therapy: European Journal of Scientific Research, Vol. 40. Euro Journal Publishing Inc, Lefkosa.

Parato KA, Senger D, Forsyth PAJ, and Bell JC. 2005. Recent Progress in the Battle Between Oncolytic Viruses and Tumours. Nature Publishing Grup, Ottawa.

Russell SJ and Peng KW. 2007. Viruses as Anticancer Drugs. Elsevier Ltd, Netherlands.

Russell SJ, Peng KW and Bell JC. 2012. Oncolytic Virotherapy. Nature American, Inc, Amerika. Shors, T. 2013. Understanding Viruses, 2nd ed, hal.301- 313. Jones & Bartlett Learning, Burlington.

Springfeld C and Cattaneo R. 2008. Oncolytic Therapy with Viruses: Encyclopedia of Cancer (Schwab M., ed), 2nd ed, hal. 2167 - 2170. Springer-Verlag Berlin Heidelberg, New York.

Vile R, Ando D, and Kirn David. 2002. The Oncolytic Virotherapy Treatment Platform for Cancer: Unique Biological and Biosafety Points to Consider. Natu e Publishing Group, Ottawa.




DOI: https://doi.org/10.33476/mkp.v5i1.1093

Refbacks

  • There are currently no refbacks.


_________________________________________________ 

Copyright of Pharmamedika Health Magazine.

Powered by OJS.

 This work is licensed under a Creative Commons Attribution- NonCommercial 4.0 International License.